Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Maceron Sep 12, 2019 6:14pm

184 Views

Post# 30121762

RE:RE:RE:RE:RE:RE:RE:RE:RE:Very oversold could surprise here with a BIG move UP .

StevenBirch wrote: Couldn't agree more.

Longholder99 wrote: This last week of trading has shown nice volume and a lot of buying up of shares. But very little SP movement. The manipulators give it a little kick in a jubblies to keep it under control by selling cheapie shares. Then they go back to accumulating. Once the weasels in control have what they want position wise. I assume we will get an NR and they will let it pop. It all seems so planned to me. But as I said before. I dont care who makes money on this and if they make more than me so be it. I'm a small retail owner. If I get to my SP target I'm happy and I'm gone. ...to the nearest boat show.

It would appear that the slope of the newly started incline matches the recent slope of the decline that we experienced after the PP was announced. Perhaps this is just a natural return to the long term moving averages after all the games htat have occured and have possibly resided.
FDA submission, additional sites, Magill treatments, patient 6 updates, more preclinical developments, REB approval for new laser. Lots to look forward too in the next few weeks.
I wouldn;t discount the possibility of a supise either.
Macer